Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

JWH-250

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
JWH-250
Legal status
Legal status
Identifiers
  • 2-(2-Methoxyphenyl)-1-(1-pentylindol-3-yl)ethanone
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC22H25NO2
Molar mass335.447 g·mol−1
3D model (JSmol)
  • COc2ccccc2CC(=O)c(c3ccccc13)cn1CCCCC
  • InChI=1S/C22H25NO2/c1-3-4-9-14-23-16-19(18-11-6-7-12-20(18)23)21(24)15-17-10-5-8-13-22(17)25-2/h5-8,10-13,16H,3-4,9,14-15H2,1-2H3 ☒N
  • Key:FFLSJIQJQKDDCM-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

JWH-250 or (1-pentyl-3-(2-methoxyphenylacetyl)indole) is ananalgesic chemical from thephenylacetylindole family that acts as acannabinoidagonist at both theCB1 andCB2 receptors, with aKi of 11 nM at CB1 and 33 nM at CB2. Unlike many of the olderJWH series compounds, this compound does not have anaphthalene ring, instead occupying this position with a 2'-methoxy-phenylacetyl group, making JWH-250 a representative member of a new class of cannabinoid ligands.[4] Other 2'-substituted analogues such as themethyl,chloro andbromo compounds are also active and somewhat more potent.[5][6]

History

[edit]

JWH-250 was discovered by, and named after the researcherJohn W. Huffman. He created JWH-250 and a number of other compounds to research the structure and function of theendocannabinoid system ofmammals. Samples of JWH-250 were first identified in May 2009 by the German Federal Criminal Police, as an ingredient in new generation "herbal smoking blends" that had been released since the banning of the original ingredients(C8)-CP 47,497 andJWH-018.[7] An ELISA immunoassay technique for detecting JWH-250 in urine has been reported.[8]

Legal status

[edit]

Australia

[edit]

JWH-250 is considered a Schedule 9 prohibited substance in Australia under thePoisons Standard (October 2015).[9] A Schedule 9 substance is a substance which may be abused or misused, the manufacture, possession, sale or use of which should be prohibited by law except when required for medical or scientific research, or for analytical, teaching or training purposes with approval of Commonwealth and/or State or Territory Health Authorities.[9]

United States

[edit]

In the United States, CB1 receptor agonists of the 3-phenylacetylindole class such as JWH-250 areSchedule I Controlled Substances.[10]

See also

[edit]

References

[edit]
  1. ^"Stoffe gem. Anlagen zum BtMG". Retrieved2024-11-23.
  2. ^Anvisa (2023-07-24)."RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese).Diário Oficial da União (published 2023-07-25).Archived from the original on 2023-08-27. Retrieved2023-08-27.
  3. ^Legal article in Latvian (www.likumi.lv)
  4. ^Huffman JW, Szklennik PV, Almond A, Bushell K, Selley DE, He H, et al. (September 2005). "1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles".Bioorganic & Medicinal Chemistry Letters.15 (18):4110–3.doi:10.1016/j.bmcl.2005.06.008.PMID 16005223.
  5. ^Manera C, Tuccinardi T, Martinelli A (April 2008). "Indoles and related compounds as cannabinoid ligands".Mini Reviews in Medicinal Chemistry.8 (4):370–87.doi:10.2174/138955708783955935.PMID 18473928.
  6. ^The Cannabinoid Receptors. Edited by Patricia H Reggio. Humana Press 2009.ISBN 978-1-58829-712-9
  7. ^"Understanding the 'Spice' phenomenon. EMCDDA, Lisbon, November 2009"(PDF). Archived fromthe original(PDF) on 2010-04-08. Retrieved2009-11-05.
  8. ^Arntson A, Ofsa B, Lancaster D, Simon JR, McMullin M, Logan B (June 2013)."Validation of a novel immunoassay for the detection of synthetic cannabinoids and metabolites in urine specimens".Journal of Analytical Toxicology.37 (5):284–90.doi:10.1093/jat/bkt024.PMID 23625703.
  9. ^abPoisons Standard October 2015https://www.comlaw.gov.au/Details/F2015L01534
  10. ^21 U.S.C. § 812:Schedules of controlled substances
Psychedelics
(5-HT2A
agonists)
Benzofurans
Lyserg‐
amides
Phenethyl‐
amines
2C-x
25x-NBx
25x-NB
25x-NB3OMe
25x-NB4OMe
25x-NBF
25x-NBMD
25x-NBOH
25x-NBOMe
Atypical structures
25x-NMx
N-(2C)-fentanyl
3C-x
4C-x
DOx
HOT-x
MDxx
Mescaline (subst.)
TMAs
  • TMA
  • TMA-2
  • TMA-3
  • TMA-4
  • TMA-5
  • TMA-6
Others
Piperazines
Tryptamines
alpha-alkyltryptamines
x-DALT
x-DET
x-DiPT
x-DMT
x-DPT
Ibogaine-related
x-MET
x-MiPT
Others
Others
Dissociatives
(NMDAR
antagonists)
Arylcyclo‐
hexylamines
Ketamine-related
PCP-related
Others
Adamantanes
Diarylethylamines
Morphinans
Others
Deliriants
(mAChR
antagonists)
Others
Cannabinoids
(CB1 agonists)
Natural
Synthetic
AM-x
CPx
HU-x
JWH-x
Misc. designer cannabinoids
D2agonists
GABAA
enhancers
Inhalants
(MixedMOA)
κORagonists
Oneirogens
Others
Opioids
Opiates/opium
Semisynthetic
Synthetic
Paracetamol-type
NSAIDs
Propionates
Oxicams
Acetates
COX-2 inhibitors
Fenamates
Salicylates
Pyrazolones
Others
Cannabinoids
Ion channel
modulators
Calcium blockers
Sodium blockers
Potassium openers
Myorelaxants
Others
Phytocannabinoids
(comparison)
Cannabibutols
Cannabichromenes
Cannabicyclols
Cannabidiols
Cannabielsoins
Cannabigerols
Cannabiphorols
Cannabinols
Cannabitriols
Cannabivarins
Delta-8-tetrahydrocannabinols
Delta-9-tetrahydrocannabinols
Delta-10-Tetrahydrocannabinols
Miscellaneous cannabinoids
Active metabolites
Endocannabinoids
Synthetic
cannabinoid
receptor
agonists /
neocannabinoids
Classical cannabinoids
(dibenzopyrans)
Non-classical
cannabinoids
Adamantoylindoles
Benzimidazoles
Benzoylindoles
Cyclohexylphenols
Eicosanoids
Indazole-3-
carboxamides
Indole-3-carboxamides
Indole-3-carboxylates
Naphthoylindazoles
Naphthoylindoles
Naphthoylpyrroles
Naphthylmethylindenes
Naphthylmethylindoles
Phenylacetylindoles
Pyrazolecarboxamides
Tetramethylcyclo-
propanoylindazoles
Tetramethylcyclo-
propanoylindoles
Others
AllostericCBRTooltip Cannabinoid receptorligands
Endocannabinoid
enhancers

(inactivation inhibitors)
Anticannabinoids
(antagonists/inverse
agonists/antibodies)
Retrieved from "https://en.wikipedia.org/w/index.php?title=JWH-250&oldid=1274427888"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp